Health Sciences Research Awards and Grants
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Street Snaps - Expression Through Photography for Older Adults Experiencing Homelessness | Grant | 5,000.00 | Other Sponsored Activity | Sheila Soto | Public Hlth Prac & Trans Rsch | Arizona Commission On the Arts | 10/2024 |
| The Ailliance Post-Market Clinical Study: All Enabling Technologies, Biologics, IDS, and Core Spine Product Collection | Contract | * | Clinical Trial | Richard Chua | Neurosurgery | Medtronic PLC, Incorporated | 10/2024 |
| Work Order to the Master Subaward Agreement for Non-Industry Funding Sources between the Children?s Hospital of Philadelphia (Chop) Contracting on Behalf of the Children?s Oncology Group (COG) | Contract | * | Clinical Trial | Holly Pariury | Cancer Center Division | Public Health Institute | 10/2024 |
| 2/2 Partnership for Native American Cancer Prevention | Cooperative Agreement | 6,587,591.00 | Research | Francine Gachupin | Cancer Center Division | National Cancer Institute | 09/2024 |
| A Phase 1 Study With ABBV-CLS-484 Alone And In Combination In Subjects With Locally Advanced or Metastatic Tumors | Contract | * | Clinical Trial | Jennifer Segar | Cancer Center Division | AbbVie Incorporated | 09/2024 |
| A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of PF-07275315 and PF-07264660 in Adult Participants With Moderate-Severe Atopic Dermatitis | Contract | * | Clinical Trial | Daniel Butler | Medicine | Pfizer, Incorporated | 09/2024 |
| A Phase 3 Randomized, Open-label Study Of Op-1250 Monotherapy Vs Standard Of Care For The Treatment Of Er+, Her2- Advanced Or Metastatic Breast Cancer Following Endocrine And Cdk 4/6 Inhibitor Therapy | Contract | * | Clinical Trial | Jennifer Segar | Cancer Center Division | PPD Development, LLC | 09/2024 |
| A Phase Ia.Ib, Open Label, Multicenter, Dose-escalation Study of BI 907828 in Patients With Advance or Metastatic Solid Tumors | Contract | * | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Boehringer Ingelheim Pharmaceuticals, Inc | 09/2024 |
| A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator's Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/ | Contract | * | Clinical Trial | Junaid Arshad | Cancer Center Division | Astrazeneca | 09/2024 |
| A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Antimicrobial Peptide PL-5 Topical Spray in Patients with Mild Infections of Diabetic Foot Ulc | Contract | * | Clinical Trial | Geoffrey Gurtner | Surgery | Parexel International Corporation | 09/2024 |
| Acculturative stress and pro-inflammatory markers among Mexican-Origin adults with NAFLD | Grant | 422,125.00 | Research | David Garcia | Health Promotion Sciences | National Institute on Minority Health and Health Disparities | 09/2024 |
| Assay Development and Prognostic Model for Predicting Early Clinical Failure in Follicular Lymphoma | Cooperative Agreement | 368,631.00 | Research | Lisa Rimsza | Pathology and Lab Medicine | National Cancer Institute | 09/2024 |
| Brightline-4: A Phase III Open-label, Single-arm, Multi-center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients With Treatment -na?ve or Pre-treated Advanced D | Contract | * | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Boehringer Ingelheim Pharmaceuticals, Inc | 09/2024 |
| Cardiac Resynchronization Therapy Using His/Left Bundle Pacing vs. Left Ventricular Epicardial Pacing in Patients with Heart Failure | Contract | * | Clinical Trial | Roderick Tung | COM Phx Internal Medicine | Baylor College of Medicine | 09/2024 |
| Community-Based Participatory Research to Enhance Vaccine Uptake Across the Lifespan through Innovative Points of Access and Altering Norms in Border and Rural Regions | Cooperative Agreement | 350,000.00 | Research | Thomas Nuno | Epidemiology and Biostatistics | Centers for Disease Control and Prevention | 09/2024 |
| Defining Mechanisms Of Cc16 On Epithelial-driven Host Responses To Pathogens | Grant | 2,411,841.00 | Research | Julie Ledford | Asthma/Airway Disease Rsch Ctr | National Heart, Lung, and Blood Institute | 09/2024 |
| Effects of Internal State on Social and Non-Social Decision Making in the Non-Human Primate Prefrontal Cortex | Fellowship | 85,776.00 | Research Training | Michael Cardenas | Physiology | National Institute of Neurological Disorders and Stroke | 09/2024 |
| Endothelial Progenitor Cells and Neurovascular Injury in the Aging Brain | Grant | 111,355.00 | Research | Kathleen Rodgers | UAHS Brain Science | University of Southern California | 09/2024 |
| Evaluating the Impact of ERPO and DVRO Firearm Relinquishment Laws on Pregnancy-Associated Homicide | Grant | 211,458.00 | Research | Maeve Wallace | Health Promotion Sciences | National Collaborative on Gun Violence Research | 09/2024 |
| Functional Interactions of Cardiac Ion Channels | Grant | 1,025,384.00 | Research | Nipavan Chiamvimonvat | COM Phx Basic Medical Sci | National Heart, Lung, and Blood Institute | 09/2024 |
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.